---
title: "Reproducibility of lncRNA VIM-AS1 as a Biomarker for TGF-β1-Driven Fibrotic Susceptibility Following Radiation Therapy"
date: "`r Sys.Date()`"
output:
  html_document:
    theme: flatly
    code_folding: hide
    toc: true
    toc_depth: 3
    toc_float: true
    fig_caption: true
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = TRUE, message = FALSE, warning = FALSE)
```
# Abstract
This report evaluates the reproducibility of results presented in (Vinasco-Sandoval et al., 2025), which investigates the role of long noncoding RNAs (lncRNAs) in breast fibrosis susceptibility following radiation therapy. The original study employed exome sequencing and RNA-seq transcriptomic profiling of primary dermal fibroblasts, identifying a 15-lncRNA signature associated with fibrosis risk, with VIM-AS1 highlighted as a key biomarker.

Our replication confirmed the upregulation of VIM-AS1, aligning with the original findings; however, discrepancies were observed concerning lncRNA 513. Furthermore, we identified only 378 differentially expressed lncRNAs, notably fewer than the 531 reported in the study. Reproduction of the heatmap required application of z-scaling and clustering procedures that were not described in the original methods, indicating that key analytical steps were omitted, thereby limiting the reproducibility of the results. This report outlines the methodology, computational workflow, and challenges encountered during reproduction.


# Introduction

Breast fibrosis is a long-term complication that can occur following radiation therapy, marked by excessive extracellular matrix deposition and tissue stiffening (Wynn, 2008). Its development varies significantly among patients, suggesting an underlying genetic or molecular predisposition. Long noncoding RNAs (lncRNAs), which regulate gene expression without coding for proteins, have emerged as potential mediators of fibrotic processes.

The original study aimed to investigate whether specific lncRNAs, particularly VIM-AS1, contribute to the risk and development of breast fibrosis after radiation therapy. By comparing gene expression profiles in skin fibroblasts from breast cancer patients with and without severe fibrosis, the authors sought to identify lncRNAs associated with fibrotic susceptibility.

Given the growing demand for transparency and reproducibility in omics research, our objective was to independently assess the robustness of these findings by reproducing the published bioinformatics workflow.

# Summary of the Paper
## Aim
This study aims to investigate how long noncoding RNAs (lncRNAs) may influence the risk and development of breast fibrosis after radiation therapy. It used gene activity profiles from skin cells of breast cancer patients with and without severe fibrosis.

## Methods
Breast cancer patients who had or had not developed severe breast fibrosis after radiation therapy were retrospectively selected from the COPERNIC collection. Exome sequencing and RNA-seq were performed on 19 primary dermal fibroblast strains isolated from the patients’ non-irradiated skin. Functional experiments were conducted using healthy donor fibroblasts and involved fibrosis induction with transforming growth factor-beta1 (TGFB1) and targeted gene knockdown.

## Results
The analysis of coding and noncoding transcriptomes successfully distinguished between patients with and without breast fibrosis. A set of 15 long noncoding RNAs (lncRNAs) was identified as a signature associated with susceptibility to fibrosis. Among these, vimentin antisense long noncoding RNA 1 (VIM-AS1) emerged as the strongest biomarker, showing the highest association with fibrosis risk based on hazard ratio analysis. Although VIM-AS1 had not been previously linked to fibrotic conditions, it was found to be upregulated in external datasets related to cardiac fibrosis.



# Experimental Design and Workflow
1. [Load Libraries](#load-libraries)  
2. [Load and Prepare Data](#load-and-prepare-data)  
3. [Pathway Enrichment Preparation](#pathway-enrichment-preparation)  
4. [Utility Functions](#utility-functions)  
5. [Volcano Plot Functions](#volcano-functions)
6. [lncRNA Differential Expression Analysis](#lncrna-differential-expression-analysis)
7. [Differential Expression Analysis](#differential-expression-analysis)  
8. [Pathway Enrichment Analysis](#pathway-enrichment-analysis)



:::::: {style="display: flex; gap: 20px;"}
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Our Workflow
```{r fig1, echo=FALSE}
knitr::include_graphics("Figure-Images/our-workflow.png")
```
:::
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Papers Workflow
```{r fig2, out.height="400px",  echo=FALSE}
knitr::include_graphics("Figure-Images/Figure1-Workflow.jpg")
```
:::
::::::
::: {style="font-size: 0.9em; font-style: italic; color: #555; margin-top: 0.5em; text-align: center;"}
**Figure 1.** Left: Our workflow for investigating differentially expressed genes between 10 fibrosis (F) and 9 non-fibrosis (NF) breast cancer patient-derived cells following radiation therapy. Right: Reference workflow from Vinasco-Sandoval et al. (2025, Figure 1A).
:::


# Evaluation of Methods and Analysis

## Methodological Justification

The study design used clinically stratified, patient-derived fibroblasts to assess intrinsic radiosensitivity. Whole exome sequencing excluded known radiosensitivity mutations. RNA-seq provided broad transcriptomic coverage. Lasso and Cox regression identified fibrosis-linked lncRNAs, with VIM-AS1 emerging as the most predictive. Validation was performed via ddPCR and functional assays in independent fibroblast systems.

## Analytical Framework

- RNA Quantification: Salmon
- Differential Expression: EdgeR
- Pathway and Functional Enrichment: ClusterProfiler, ReactomePA
- Predictive Modelling: Lasso and Cox regression (R)
- Validation Techniques: ddPCR, RT-qPCR, flow cytometry, 3D collagen contraction assay
- Post-Knockdown Analysis: Weighted gene co-expression network analysis (WGCNA)
- Statistical Testing: Wilcoxon-Mann-Whitney, t-test, Kruskal-Wallis, ANOVA (GraphPad Prism)

## Strengths
- Use of primary patient-derived cells with known clinical outcomes
- Exclusion of genetic confounders
- Multi-modal validation from RNA to function
- Reproducibility using independent ASOs

## Limitations
- No explicit discussion of method limitations in the paper
- Lack of tissue-level validation
- No comparison with alternative modelling approaches

## Impact on Results
The methodological design enabled identification and validation of fibrosis-linked lncRNAs. VIM-AS1 was confirmed as a key biomarker with regulatory effects on ECM, cell cycle, and DNA repair pathways. The study provides a strong foundation for transcriptomic risk stratification in radiotherapy-induced fibrosis.

# Evaluation of Reproduced Results

## Data
### GSE256420 Patients Raw Counts Data Set

- 16,123 instances (genes)

- 3 categorical attributes:
  - **Gene\_ID**: Ensembl ID with version
  - **Gene\_Name**: Official Gene Symbol
  - **BioType**: *protein-coding* or *lncRNA*
  
- 12 numerical attributes:
  - Raw expression counts across 12 samples (F01–F06, NF01–NF06)

### GSE256420 Additional Patients Raw Counts Data Set

- 18,201 instances (genes)

- 3 categorical attributes:
  - **Gene\_ID**: Ensembl ID with version
  - **Gene\_Name**: Official Gene Symbol
  - **BioType**: *protein-coding* or *lncRNA*
  
- 7 numerical attributes:
  - Raw expression counts across 7 samples (F07–F10, NF07–NF09)
  
Expression profiling by high-throughput sequencing; data retrieved from the Gene Expression Omnibus: [GSE256420](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE256420)

### Load Libraries
```{r load-libraries}
# ═══════════════════════════════════════════════════════════════════════════════
# PACKAGE LOADING
# ═══════════════════════════════════════════════════════════════════════════════

# Data manipulation and visualization
library(tidyverse)
library(ggfortify)
library(ggplot2)
library(ggrepel)
library(RColorBrewer)

# Bioconductor packages for genomic data
library(GEOquery)
library(org.Hs.eg.db)
library(limma)
library(edgeR)
library(Glimma)

# Pathway enrichment analysis
library(ReactomePA)
library(clusterProfiler)
library(AnnotationDbi)
library(Homo.sapiens)
library(reactome.db)

# Heatmap and visualization
library(ComplexHeatmap)
library(SummarizedExperiment)
library(gplots)
library(pheatmap)

# Visuals
library(patchwork)
```

### Load And Prepare Data
```{r load-and-prepare-data}
# ═══════════════════════════════════════════════════════════════════════════════
# DATA IMPORT AND PREPROCESSING
# ═══════════════════════════════════════════════════════════════════════════════

# Load raw count datasets
raw_patient_data <- read.delim(
  "data/GSE256420_patients_raw_counts.txt", 
  check.names = FALSE
)

additional_raw_patient_data <- read.delim(
  "data/GSE256420_additional_patients_raw_counts.txt", 
  check.names = FALSE
)

# Extract sample data (remove duplicate gene annotations)
additional_raw_patient_sample_data <- additional_raw_patient_data[, -c(2:3)]

# Merge datasets by Gene_ID
combined_raw_patient_data <- merge(
  raw_patient_data,
  additional_raw_patient_sample_data,
  by = "Gene_ID"
)

# ───────────────────────────────────────────────────────────────────────────────
# CREATE DATA STRUCTURES
# ───────────────────────────────────────────────────────────────────────────────

# Count matrix (genes × samples)
counts <- as.matrix(combined_raw_patient_data[, -(1:3)])

# Gene annotations
genes <- data.frame(
  Gene_Name = combined_raw_patient_data$Gene_Name,
  Biotype = combined_raw_patient_data$Biotype,
  row.names = make.unique(combined_raw_patient_data$Gene_ID)
)

# Sample metadata (F = Fibrotic, NF = Non-Fibrotic)
samples <- data.frame(
  group = factor(
    ifelse(grepl("^F", colnames(counts)), "F", "NF"), 
    levels = c("NF", "F")
  ),
  row.names = colnames(counts)
)

# ───────────────────────────────────────────────────────────────────────────────
# SUBSET BY BIOTYPE
# ───────────────────────────────────────────────────────────────────────────────

lncRNA_data <- combined_raw_patient_data %>% 
  filter(Biotype == "lncRNA")

protein_coding_data <- combined_raw_patient_data %>% 
  filter(Biotype == "protein-coding")
```

### Pathway Enrichment Preparation
```{r pathway-enrichment-preparation}
# ═══════════════════════════════════════════════════════════════════════════════
# PATHWAY ANALYSIS PREPARATION
# ═══════════════════════════════════════════════════════════════════════════════

# Convert gene symbols to ENTREZ IDs
gene_entrez_ids <- clusterProfiler::bitr(
  combined_raw_patient_data$Gene_Name, 
  fromType = "SYMBOL", 
  toType = "ENTREZID", 
  OrgDb = org.Hs.eg.db
)

# Perform Reactome pathway enrichment
pathway_enrichment <- enrichPathway(
  gene = gene_entrez_ids$ENTREZID, 
  organism = "human"
)
```

### Untility Functions
```{r utility-functions}
# ═══════════════════════════════════════════════════════════════════════════════
# UTILITY FUNCTIONS
# ═══════════════════════════════════════════════════════════════════════════════

get_genes_counts_samples <- function(data) {
  # Extract components from dataset
  genes <- data.frame(
    Gene_Name = data$Gene_Name,
    Biotype = data$Biotype,
    row.names = make.unique(data$Gene_ID)
  )
  
  counts <- as.matrix(data[, -(1:3)])
  
  samples <- data.frame(
    group = factor(
      ifelse(grepl("^F", colnames(counts)), "F", "NF"), 
      levels = c("NF", "F")
    ),
    row.names = colnames(counts)
  )
  
  return(list(genes = genes, counts = counts, samples = samples))
}

# ───────────────────────────────────────────────────────────────────────────────

edger_dge_analysis <- function(genes, counts, samples) {
  # Standard edgeR pipeline
  dge <- DGEList(counts = counts, group = samples$group, genes = genes)
  dge <- dge[filterByExpr(dge), , keep.lib.sizes = FALSE]
  dge <- calcNormFactors(dge, method = "TMM")
  dge <- estimateDisp(dge)
  
  # Differential expression testing
  et <- exactTest(dge)
  results <- topTags(et, n = Inf)$table
  
  return(results)
}

# ───────────────────────────────────────────────────────────────────────────────

get_pathway_specific_gene_dataset <- function(search, data) {
  # Find matching pathways
  pathway <- subset(pathway_enrichment@result, grepl(search, Description))
  
  # Extract and convert gene IDs
  gene_ids_list <- pathway$geneID
  gene_entrez_ids <- unlist(strsplit(gene_ids_list, split = "/"))
  
  gene_symbols <- clusterProfiler::bitr(
    gene_entrez_ids, 
    fromType = "ENTREZID", 
    toType = "SYMBOL", 
    OrgDb = org.Hs.eg.db
  )
  
  # Filter dataset
  subset_data <- data %>% 
    filter(Gene_Name %in% gene_symbols$SYMBOL)
  
  return(subset_data)
}
```
### Volcano Functions
```{r volcano-functions}
# ═══════════════════════════════════════════════════════════════════════════════
# VISUALIZATION FUNCTIONS
# ═══════════════════════════════════════════════════════════════════════════════

plot_pretty_volcano <- function(results, 
                                logFC_limit = 2.5, 
                                pval_threshold = 0.05, 
                                fc_threshold = 1.5, 
                                highlight_n = 20) {
  
  # Define significance categories
  results$Significance <- ifelse(
    results$logFC > 0 & 
    results$PValue < pval_threshold & 
    abs(results$logFC) >= log2(fc_threshold), 
    "Up",
    ifelse(
      results$logFC < 0 & 
      results$PValue < pval_threshold & 
      abs(results$logFC) >= log2(fc_threshold), 
      "Down", 
      "NS"
    )
  )
  
  # Prepare gene labels
  results$label <- ifelse(results$Significance != "NS", results$Gene_Name, NA)
  
  results <- results %>% 
    mutate(rank = -log10(PValue)) %>%
    arrange(desc(rank)) %>%
    mutate(label = ifelse(row_number() <= highlight_n, label, NA))

  # Create volcano plot
  ggplot(results, aes(x = logFC, y = -log10(PValue))) +
    geom_point(aes(colour = Significance), 
               alpha = 0.7, size = 2) +
    geom_text_repel(aes(label = label), 
                    size = 3, max.overlaps = Inf, 
                    segment.curvature = 0, segment.color = NA) +
    scale_colour_manual(values = c("Up" = "red", "Down" = "blue", "NS" = "grey")) +
    geom_vline(xintercept = c(-log2(fc_threshold), log2(fc_threshold)), 
               linetype = "dashed", colour = "black") +
    geom_hline(yintercept = -log10(pval_threshold), 
               linetype = "dashed", colour = "black") +
    coord_cartesian(xlim = c(-logFC_limit, logFC_limit)) +
    theme_classic(base_size = 13) +
    theme(legend.position = "none") +
    labs(x = "Log2 Fold Change", y = "-log10 (P-value)")
}

# ───────────────────────────────────────────────────────────────────────────────

create_pretty_volcano <- function(data) {
  res <- get_genes_counts_samples(data)
  results <- edger_dge_analysis(res$genes, res$counts, res$samples)
  plot_pretty_volcano(results)
}

# ───────────────────────────────────────────────────────────────────────────────

create_pathway_specific_volcano <- function(search, data) {
  subset_data <- get_pathway_specific_gene_dataset(search, data)
  res <- get_genes_counts_samples(subset_data)
  results <- edger_dge_analysis(res$genes, res$counts, res$samples)
  plot_pretty_volcano(results)
}
```

### lncRNA Differential Expression Analysis
```{r lncRNA-differential-expression-analysis}
# ═══════════════════════════════════════════════════════════════════════════════
# LNCRNA ANALYSIS PIPELINE  
# ═══════════════════════════════════════════════════════════════════════════════

# Prepare lncRNA-specific data
lncRNA_counts <- lncRNA_data[, -(1:3)]

lncRNA_genes <- data.frame(
  Gene_ID = lncRNA_data$Gene_ID,
  Gene_Name = lncRNA_data$Gene_Name,
  Biotype = lncRNA_data$Biotype
)

lncRNA_group <- factor(
  ifelse(grepl("^F", colnames(lncRNA_counts)), "F", "NF"), 
  levels = c("NF", "F")
)

# ───────────────────────────────────────────────────────────────────────────────
# DIFFERENTIAL EXPRESSION ANALYSIS
# ───────────────────────────────────────────────────────────────────────────────

# Standard edgeR workflow
lncRNA_dge <- DGEList(
  counts = lncRNA_counts, 
  group = lncRNA_group, 
  genes = lncRNA_genes
)

lncRNA_dge <- lncRNA_dge[filterByExpr(lncRNA_dge), , keep.lib.sizes = FALSE]
lncRNA_dge <- calcNormFactors(lncRNA_dge)
lncRNA_dge <- estimateDisp(lncRNA_dge)

# Statistical testing
lncRNA_expression_test_results <- exactTest(lncRNA_dge)
lncRNA_results <- topTags(lncRNA_expression_test_results, n = Inf)$table

# ───────────────────────────────────────────────────────────────────────────────
# FILTER SIGNIFICANT GENES
# ───────────────────────────────────────────────────────────────────────────────

# Apply significance thresholds (P < 0.05, |FC| >= 1.5)
lncRNA_significant_genes_filter <- lncRNA_results$PValue < 0.05 & 
                                   abs(lncRNA_results$logFC) >= log2(1.5)

significant_results <- lncRNA_results[lncRNA_significant_genes_filter, ]
significant_gene_ids <- rownames(significant_results)

# Create filtered DGE object for visualization
lncRNA_filtered_dge <- lncRNA_dge[rownames(lncRNA_dge) %in% significant_gene_ids, ]
```

## Differential Expression Analysis
### PCA
```{r pca}

# ═══════════════════════════════════════════════════════════════════════════════
# PCA VISUALIZATION
# ═══════════════════════════════════════════════════════════════════════════════

# Calculate log-CPM for significant lncRNAs
lcpm <- cpm(lncRNA_filtered_dge, log = TRUE, prior.count = 1)

# Perform PCA (samples as observations)
pca <- prcomp(t(lcpm), scale = TRUE)

# Prepare sample metadata
sample_info <- data.frame(
  Sample = colnames(lcpm),
  Group = lncRNA_group
)

# Generate PCA plot
autoplot(pca, data = sample_info, colour = "Group") +
  theme_minimal()
```

::: {style="font-size: 0.9em; font-style: italic; color: #555; margin-top: 0.5em; text-align: center;"}
**Figure 2.** Principal component analysis (PCA) of log-transformed counts per million (log-CPM) for significant long noncoding RNAs (lncRNAs), showing sample clustering between 10 fibrosis (F) and 9 non-fibrosis (NF) breast cancer patient cells based on papers data (Vinasco-Sandoval et al. 2025). This analysis was independently performed in this study.
:::

Principal component analysis of log-CPM values for significant lncRNAs showed that PC1 explained 52.81% of the variance and PC2 explained 7.53%, with clear separation between fibrosis (F) and non-fibrosis (NF) samples, indicating that these components effectively distinguish the two groups based on lncRNA expression profiles (Figure 2).

### Heatmap
:::::: {style="display: flex; gap: 20px;"}
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Our Heatmap Plot
```{r heatmap}
# ═══════════════════════════════════════════════════════════════════════════════
# HEATMAP GENERATION
# ═══════════════════════════════════════════════════════════════════════════════

# Prepare expression data
lcpm <- cpm(lncRNA_filtered_dge, log = TRUE, prior.count = 1)

# Create sample metadata
samples <- data.frame(
  sample_id = colnames(lcpm),
  group = factor(
    ifelse(grepl("^F", colnames(lcpm)), "F", "NF"), 
    levels = c("NF", "F")
  )
)
rownames(samples) <- samples$sample_id

# ───────────────────────────────────────────────────────────────────────────────
# SAMPLE ORDERING AND NORMALIZATION
# ───────────────────────────────────────────────────────────────────────────────

# Order samples: NF first, then F
nf_samples <- rownames(samples)[samples$group == "NF"]
f_samples <- rownames(samples)[samples$group == "F"]
manual_order <- c(nf_samples, f_samples)

# Reorder data
lcpm <- lcpm[, manual_order]
samples <- samples[manual_order, , drop = FALSE]

# Z-score normalization by gene
lcpm <- t(scale(t(lcpm)))

# ───────────────────────────────────────────────────────────────────────────────
# HEATMAP STYLING
# ───────────────────────────────────────────────────────────────────────────────

# Define colors and annotations
sample_annotation <- samples["group"]
rownames(sample_annotation) <- rownames(samples)

annotation_colors <- list(Condition = c(NF = "#98cc32", F = "#000000"))
my_colors <- colorRampPalette(c("#6a3fff", "#FFFFFF", "#fc3e1c"))(100)

# Create column annotation
col_heatmap_annotation <- HeatmapAnnotation(
  Condition = sample_annotation$group,
  col = annotation_colors,
  show_annotation_name = TRUE,
  annotation_name_side = "right"
)

# ───────────────────────────────────────────────────────────────────────────────
# GENERATE HEATMAP
# ───────────────────────────────────────────────────────────────────────────────

ht_opt$message = FALSE

Heatmap(
  lcpm,
  col = my_colors,
  cluster_rows = FALSE,
  cluster_columns = TRUE,
  show_row_names = FALSE,
  show_column_names = TRUE,
  top_annotation = col_heatmap_annotation,
  column_gap = unit(4, "mm"),
  column_split = c(rep("NF", 9), rep("F", 10)),
  heatmap_legend_param = list(
    at = range(lcpm, na.rm = TRUE),
    labels = c("DOWN", "UP"),
    title = "Expression",
    legend_height = unit(4, "cm"),
    direction = "vertical"
  ),
  use_raster = TRUE,
  clustering_method_rows = "ward.D2",
  clustering_method_columns = "complete",
  row_km = 2,
  row_title = NULL
)
```
:::
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Paper Heatmap Plot
![](Figure-Images/Figure2-Heatmap.jpg)
:::
::::::

::: {style="font-size: 0.9em; font-style: italic; color: #555; margin-top: 0.5em; text-align: center;"}
**Figure 3.** Heatmap comparison showing the differential expression of 531 long noncoding RNAs (lncRNAs) between 10 fibrosis (F, black) and 9 non-fibrosis (NF, green) breast cancer patient samples treated with radiation therapy. (Left) Heatmap generated in this study based on log2-transformed counts per million (CPM). (Right) Heatmap from (Vinasco-Sandoval et al. 2025, Figure 1A), illustrating the noncoding transcriptome’s ability to discriminate fibrosis from nonfibrosis patients (Vinasco-Sandoval et al., 2025).
:::

### Strengths

- Successfully reproduced the heatmap of differentially expressed lncRNAs distinguishing fibrosis (F) and non-fibrosis (NF) samples using EdgeR-filtered data and log2 CPM normalisation as per the paper ([lncRNA Differential Expression Analysis](#lncrna-differential-expression-analysis)).
- Data were normalised with R’s `cpm` function, and samples ordered by group (NF then F) to match the original figure.
- Z-score scaling by gene was applied for clarity, although not specified by the authors ([Heatmap Code](#heatmap)).
- The heatmap clearly separated groups, supporting the original findings (Figure 3).

### Weaknesses

- The original study did not specify the use of Z-score scaling, making this an interpretive step.
- Clustering parameters (distance metric, linkage) were not detailed, which may cause minor differences in sample grouping.
- These gaps represent minor reproducibility limitations affecting exact figure replication.


### Volcano
:::::: {style="display: flex; gap: 20px;"}
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Our Volcano Plot 
```{r volcano}
# ═══════════════════════════════════════════════════════════════════════════════
# VOLCANO PLOT VISUALIZATION
# ═══════════════════════════════════════════════════════════════════════════════

# Categorize genes by significance
volcano_data <- lncRNA_results %>%
  mutate(Significance = case_when(
    PValue < 0.05 & abs(logFC) >= log2(1.5) & logFC > 0 ~ "Upregulated",
    PValue < 0.05 & abs(logFC) >= log2(1.5) & logFC < 0 ~ "Downregulated",
    TRUE ~ "Not-Significant"
  ))

# Count significant genes
up_count <- sum(volcano_data$Significance == "Upregulated")
down_count <- sum(volcano_data$Significance == "Downregulated")

# Select top genes for labeling
top_genes <- volcano_data %>%
  filter(Significance != "Not-Significant") %>%
  arrange(PValue) %>%
  head(15)

# ───────────────────────────────────────────────────────────────────────────────
# CREATE VOLCANO PLOT
# ───────────────────────────────────────────────────────────────────────────────

ggplot(volcano_data, aes(x = logFC, y = -log10(PValue))) +
  geom_point(aes(colour = Significance), alpha = 0.7, size = 2) +
  geom_text_repel(data = top_genes, aes(label = Gene_Name), 
                  size = 3, max.overlaps = Inf) +
  scale_colour_manual(values = c(
    "Upregulated" = "red", 
    "Downregulated" = "blue", 
    "Not-Significant" = "grey"
  )) +
  geom_vline(xintercept = c(-log2(1.5), log2(1.5)), linetype = "dashed") +
  geom_hline(yintercept = -log10(0.05), linetype = "dashed") +
  theme_classic(base_size = 13) +
  theme(
    legend.title = element_blank(),
    legend.position = "top",
    plot.margin = margin(10, 15, 10, 10)
  ) +
  labs(
    x = "Log2 FoldChange", 
    y = "-Log10 (P-value)"
  ) +
  coord_cartesian(xlim = c(-4.5, 4.5), ylim = c(0, 7)) +
  annotate("text", x = 4.2, y = 6.4, label = paste(up_count, "lncRNAs"),
           colour = "red", size = 4, hjust = 1) +
  annotate("text", x = -4.2, y = 6.4, label = paste(down_count, "lncRNAs"),
           colour = "blue", size = 4, hjust = 0)
```
:::
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Paper Volcano Plot
![](Figure-Images/Figure2-Volcano.jpg)
:::
::::::

::: {style="font-size: 0.9em; font-style: italic; color: #555; margin-top: 0.5em; text-align: center;"}
**Figure 4.** Volcano plot comparison showing the differential expression of long noncoding RNAs (lncRNAs) between 10 fibrosis (F) and 9 non-fibrosis (NF) breast cancer patient samples treated with radiation therapy. (Left) Volcano plot generated in this study displaying significant upregulated (red) and downregulated (blue) lncRNAs with top 15 genes labelled, based on independent analysis of data from Vinasco-Sandoval et al. (2025). (Right) Volcano plot from (Vinasco-Sandoval et al. 2025, Figure 2A), illustrating the noncoding transcriptome’s ability to discriminate fibrosis from nonfibrosis patients.
:::

### Strengths

- Differential expression analysis was conducted using EdgeR, applying the criteria of P < 0.05 and absolute fold change ≥ 1.5, consistent with the original study ([lncRNA Differential Expression Analysis](#lncrna-differential-expression-analysis), [volcano Code](#volcano)).
- The analysis identified 378 differentially expressed lncRNAs, capturing significant transcriptional differences between fibrosis (F) and non-fibrosis (NF) samples.
- The reproduced volcano plot clearly reflected group separation, supporting the original findings and confirming that the noncoding transcriptome discriminates patient groups (Figure 4).

### Weaknesses

- The number of differentially expressed lncRNAs (378) was fewer than the 531 reported in the original study.
- This discrepancy likely results from undocumented differences in pre-processing, gene filtering, or software versions affecting gene inclusion before differential analysis.
- Insufficient methodological detail in the original paper limits exact reproducibility and represents a reproducibility limitation.


## Pathway Enrichment Analysis
:::::: {style="display: flex; gap: 20px;"}
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Our Volcano Plots
```{r pathway-specific-volcano, fig.width=10, fig.height=18}
plot_A <- create_pathway_specific_volcano("TGFB", protein_coding_data) +
  ggtitle("A") +
  theme(plot.title = element_text(hjust = 0, size = 16, face = "bold", margin = margin(b = 20)))
plot_B <- create_pathway_specific_volcano("Extracellular matrix organization", protein_coding_data) +
  ggtitle("B") +
  theme(plot.title = element_text(hjust = 0, size = 16, face = "bold", margin = margin(b = 20)))
plot_C <- create_pathway_specific_volcano("Collagen formation|Collagen biosynthesis", protein_coding_data) +
  ggtitle("C") +
  theme(plot.title = element_text(hjust = 0, size = 16, face = "bold", margin = margin(b = 20)))

combined_plot <- plot_A / plot_B / plot_C + 
  plot_layout(ncol = 1, heights = c(1, 1, 1)) & 
  theme(plot.margin = margin(10, 10, 10, 10))

combined_plot

```
:::
::: {style="flex: 1; text-align: center; font-weight: bold;"}
Paper Volcano Plots
![](Figure-Images/Figure1-Volcano.jpg)
:::
::::::

::: {style="font-size: 0.9em; font-style: italic; color: #555; margin-top: 0.5em; text-align: center;"}
**Figure 5.** Pathway-specific volcano plots showing differential expression of protein-coding genes related to (A) TGFB signalling, (B) Extracellular matrix organization, and (C) Collagen formation/biosynthesis between fibrosis (F) and non-fibrosis (NF) breast cancer patient samples treated with radiation therapy. (Left) Volcano plots generated in this study based on independent analysis of the data. (Right) Corresponding volcano plots from (Vinasco-Sandoval et al. 2025, Figure 1(C-E)), illustrating pathway enrichment linked to fibrosis susceptibility.
:::

### Strengths

- Differential expression analysis of protein-coding genes was performed using EdgeR with the same criteria as the original study (P < 0.05, |fold change| ≥ 1.5), yielding 1,854 differentially expressed mRNAs, which is slightly lower than the 2,162 reported, possibly due to differences in filtering or annotation.
- Functional enrichment analysis using ReactomePA identified significantly enriched pathways, including TGFB signalling, extracellular matrix organisation, and collagen synthesis (FDR < 0.05).
- Pathway-specific volcano plots were successfully generated by filtering genes within each Reactome pathway that met the differential expression thresholds ([Pathway Enrichment Preparation](#pathway-enrichment-preparation), [Pathway Volcano Code](#pathway-specific-volcano)).
- The reproduced plots captured key pathway-level expression differences between fibrosis and non-fibrosis samples, supporting the original study’s conclusions (Figure 5, left; Vinasco-Sandoval et al. 2025, Figure 1C–E).

### Weaknesses

- Exact reproduction was limited by insufficient detail on pathway filtering and gene-to-pathway mapping procedures in the original methods.
- The paper did not specify the Reactome database version used or the precise logic for subsetting differentially expressed genes for these plots.
- These methodological gaps represent a reproducibility limitation despite the overall success in reproducing key pathway-level patterns.

# Conclusion and Future Directions

This reproduction study confirms the central findings of the original analysis—most notably the differential expression of **VIM-AS1**, a lncRNA associated with radiation-induced fibrosis. Through independent processing, we successfully validated core visual and statistical outputs, including the heatmap, volcano plots, and pathway-specific analyses. These results underscore the biological relevance of both coding and noncoding transcriptomic differences between fibrosis and non-fibrosis samples.

However, key reproducibility issues were encountered:

- Only **378 differentially expressed lncRNAs** were identified, compared to **531 reported**. This discrepancy likely reflects undocumented preprocessing steps.
- **Z-score scaling and clustering** were required to reproduce the heatmap, yet these steps were not described in the original methods, suggesting critical omissions.
- The **absence of code**, **unclear gene filtering**, **undefined visualisation parameters**, and **incomplete Reactome pathway reporting** all limit transparency and hinder replication.

Despite these gaps, the study’s major conclusion—**VIM-AS1 upregulation in fibrosis**—was independently confirmed, reinforcing its potential as a fibrosis biomarker and validating the utility of public RNA-seq data.

## Recommendations for Future Studies

- Release full analysis code and workflows, including filtering, transformation, and clustering steps.
- Clearly report all figure parameters, such as scaling methods, clustering settings, and distance/linkage metrics.
- Specify pathway enrichment tool versions and gene-to-pathway mapping strategies.
- Embed reproducibility checks into RNA-seq pipelines, making validation easier across studies.

Improved methodological transparency will enable more consistent cross-study validation and accelerate progress in uncovering regulatory roles of the noncoding transcriptome in fibrosis.

# References

1. Deleuze, J.-F., Foray, N., Fortunel, N. O., & Martin, M. T. (2025). Long Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility After Radiation Therapy and Promoter of Transforming Growth Factor Beta1-Driven Fibrosis. International Journal of Radiation Oncology*Biology*Physics, 121(3), 783-797. https://doi.org/https://doi.org/10.1016/j.ijrobp.2024.09.049 
2. Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. J Pathol, 214(2), 199-210. https://doi.org/10.1002/path.2277 